Avidity Biosciences
100 hedge funds and large institutions have $739M invested in Avidity Biosciences in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+18
Holders Change %
+21.95%
% of All Funds
1.76%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
43
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$38.3M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$29.4M |
| 3 |
3
BlackRock
New York
|
$58.7M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$28M |
| 5 |
5
Federated Hermes
Pittsburgh,
Pennsylvania
|
$39.3M |
